10nm.
The New Standard.
Redefining molecular transport with the world's smallest liposome technology for non-destructive cellular entry.
Neutral charge surface
Breaching the
Barrier.
99.9% of drugs cannot penetrate the blood-brain barrier. We are changing that reality.
Molecular Size Limit
Only lipid-soluble molecules under 400 Daltons can cross the BBB passively. Most biologics are far too large for standard transport.
Active Transport
Existing technologies rely on saturable receptor-mediated transport, significantly limiting dosage effectiveness and window.
Small Molecular Insertion
Our 4-10nm fibers bypass receptors entirely, inserting directly into leaflets for non-destructive, high-volume entry.
A Seamless Path to
Brain Delivery
Formulation Assembly
Self-assembly of 10nm lipid fibers encapsulating the therapeutic payload in a stable, neutral-charge matrix.
Circulation Stability
Stealth coating prevents immune recognition and protein adsorption, ensuring prolonged half-life in the bloodstream.
Transient Pore Crossing
Contact with BBB endothelial cells triggers temporary pore formation, allowing rapid cytosolic entry without toxicity.
Intracellular Release
Payload is released directly into the cytosol or nucleus, bypassing endosomal entrapment entirely.
The $7 Billion
Opportunity
The global CNS drug delivery market is severely underserved. Atom Bios unlocks the potential for next-generation biologics in neurology.
Percentage of CNS diseases with no effective cure due to delivery barriers.
Data based on preclinical murine models (2024).
Excellence in
Innovation
PolyU Micro Fund
Top Performer
HKSTP Ideation
Programme Member
PolyU GBA Innovation
Incubation Programme
Hong Kong Techathon+
Life Science & Healthcare - Gold Award
The Team
Ng Cheuk Hei
PhD Candidate / Drug Discovery State Key Researcher
Research & Development
Dr. Abdullah Shaik
Preclinical Research
HKU Med
Dr. Tse ZI Chang's Team
Delivery System Optimization
Huazhong Univ. of Sci & TechBusiness & IT
Lo Yik Sze
Co-FounderTech / Marketing
HKPolyU
Tsang Hin Sing
Co-FounderFund Raising / Tech
HKPolyU
Prof. Wong KY
State Key Director for Chemical Biology and Drug Discovery
Let’s Redefine
Medicine Together
Partner with us to unlock the potential of 10nm delivery. We are actively seeking pharmaceutical collaborations and strategic investment.
Partner with Us
For pharmaceutical companies looking to leverage our 10nm platform for CNS drug delivery.
Investor Relations
For institutional investors interested in supporting the next generation of biotech.